4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000047
CFO and Secretary sold 10,757 shares at $13.57 ($146,004)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Adam Scott CFO and Secretary | 2024-10-11 | Sale 10b5-1 | −10,757 | $13.57 | $146,004 | 236,854 | D |
| Open-market sales · 10,757 sh · avg $13.57 · $146,004 | |||||||
Loading xslF345X05/wk-form4_1729023737.xml…